Collaborative Study: The Protective Value of Medical Data
The purpose of this study was to evaluate the protective value offered by IntelliScript’s Medical Data product and the types of risks/impairments that it helps identify.
Underwriting
Milliman Irix® – Risk Score with Medical Data
Munich Re Life US assessed Milliman Irix® – Risk Score with Medical Data, a predictive modeling tool developed and owned by Milliman that assesses mortality risk through the combination of an individual’s prescription drug history and medical claims records.
$2.6 Billion of Protective Value Identified Through Paramed and Laboratory Underwriting Evidence
A recent article published by Clinical Reference Lab and ExamOne showed the protective value for tobacco testing exceeded $4 billion. Using the same time frame (2015-2022) and 18 million record dataset, we now describe the additional value associated with testing for undiagnosed diabetes and hypertension worth $2.6 billion.
Remember to Forget – Insuring Cancer Survivors and the Right to be Forgotten
The number of people living after a cancer diagnosis (i. e. prevalent cases) has been increasing for the past 30 years, reaching around 5 % of the total population in several countries.
How Covid Has Changed the Life Insurance Marketplace
The industry is still wrestling with mortality assumptions related to Covid-19, and how shifts may affect the life insurance underwriting process.
Assessing Foreign Travel Risk Presents a Moving Target
RGA's Melissa Gallegos provides an overview of current foreign travel risk and urges insurers to remain vigilant and view every country as a world of its own.
Motor Vehicle Records Data and Life Insurance
As younger, tech-savvy consumers have increasingly completed their purchasing online, many life insurers have seized this opportunity to update and redesign their application and underwriting processes.
The Role of Data in the Post-Pandemic Underwriting Process
In just a few months’ time, the COVID-19 crisis brought about years of change in the way companies in all sectors and regions do business. According to a new McKinsey Global Survey of executives, their companies have accelerated the digitization of their customer and supply-chain interactions and of their internal operations by 3 to 4 years. And the share of digital or digitally enabled products in their portfolios has accelerated by a shocking 7 years. The insurance industry is no exception.
Principles of Alternative Data for Underwriting
Part 1 in a series of 2 articles: Principles to consider
Impaired Risk Life Underwriting: Evolving With The Process
When asked to write on advances in impaired risk underwriting, I began to question the term “advances.”